A short history of Japanese medicine; an alternative view - by P Reed Maurer

27 June 2013

The first recorded outside medical influence on Japan was traditional Chinese medicine introduced via Korea in the 5th century. Diagnosis (Chung-i) was based primarily upon meticulous palpation of the pulse at each wrist. The therapeutic approach was via medicines, acupuncture, and moxibustion. Ginseng and powdered horn were the chief therapeutic agents. Among Japanese these influences continue to persist today, 1600 years later, says P Reed Maurer, long-time Japanese pharma industry watcher and president of International Alliances Limited (IAL), in an exclusive article for The Pharma Letter.

The first Westerners to arrive in Japan were not doctors. They were Portuguese sailors blown ashore at Tanegashima in 1542. Interesting quirk of history that this site is now where Japan launches its satellites into space. And the lasting influence of people from Portugal is tempura, now considered fine Japanese cuisine.

Americans did not come to Japan until 1853, 300 years after the Europeans
By the 16th century, indigenous schools of medicine were well established in Japan. They emphasized the priestly role of physicians and medical practices which were closely guarded secrets. In one school there were 17 rules to be strictly observed.  A few of them are as follows:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical